Leadership transition New CEO Michael Koffler appointed in May 2024 presents an opportunity to engage with executive leadership on strategic IT management initiatives, healthcare technology integration, and potential refresh or expansion of service contracts.

Acquisition history The InterMed Group has a track record of acquisitions (e.g., Modern Biomedical in 2021) which signals openness to inorganic growth and potential interest from private equity-backed buyers or strategic partners for technology management services.

CYBER security focus In response to rising healthcare cyber threats, InterMed launched a cohesive cybersecurity suite for ultrasound services in 2021, indicating a strong cross-sell opportunity for comprehensive security solutions across their asset management and telehealth technology stack.

Tech-enabled services The company emphasizes integrated technology management and maintains a diverse tech stack (Microsoft Office, Visio, jQuery Mobile, multimedia platforms), suggesting opportunities to upsell IT governance, workflow optimization, and interoperability solutions for medical devices.

Growth via partnerships Private equity-backed acquisition activity and leadership changes indicate a potential appetite for strategic partnerships, managed services agreements, or co-investment deals with healthcare technology management providers to expand capabilities and geographic reach.